Scienture Holdings Inc
Follow $SCNX
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $SCNX by emailVeridion Score
BETALOW CONF · 4 of 6 factors measuredHighest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is SCNX moving today?
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
SCNX overview
Related filings and maps
Congress activity in SCNX
No receipt-qualified Congressional disclosure is present for SCNX in the cached public ledger.
SCNX contract awards, year to date.
Public federal awards linked to this ticker.
SCNX lobbying filings, year to date.
Registered lobbying filings matched to Scienture Holdings Inc.